19-6495769-C-T
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The ENST00000264071.7(TUBB4A):c.730G>A(p.Gly244Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G244D) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000264071.7 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TUBB4A | NM_006087.4 | c.730G>A | p.Gly244Ser | missense_variant | 4/4 | ENST00000264071.7 | NP_006078.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TUBB4A | ENST00000264071.7 | c.730G>A | p.Gly244Ser | missense_variant | 4/4 | 1 | NM_006087.4 | ENSP00000264071 | P1 | |
TUBB4A | ENST00000594276.5 | c.418G>A | p.Gly140Ser | missense_variant | 3/3 | 4 | ENSP00000472481 | |||
TUBB4A | ENST00000594075.5 | downstream_gene_variant | 3 | ENSP00000469936 | ||||||
TUBB4A | ENST00000600216.5 | downstream_gene_variant | 5 | ENSP00000470983 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 33
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Hypomyelinating leukodystrophy 6 Pathogenic:2Other:1
Likely pathogenic, criteria provided, single submitter | clinical testing | Molecular Diagnostics Lab, Nemours Children's Health, Delaware | Dec 30, 2020 | This missense variant (c.730G>A, p.Gly244Ser) has not been observed in population databases (gnomAD). It has been reported in the literature (PMID24785942). Variant prediction programs suggest a deleterious effect, although no functional studies have been published. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Jul 17, 2023 | Variant summary: TUBB4A c.730G>A (p.Gly244Ser) results in a non-conservative amino acid change located in the GTPase domain (IPR003008) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 251384 control chromosomes (gnomAD). c.730G>A has been reported in the literature in at least five individuals affected with Hypomyelinating Leukodystrophy, including several de novo occurrences (e.g., Hamilton_2014, Carvalho_2015, Gavazzi_2021). These data indicate that the variant is very likely to be associated with disease. The following publications have been ascertained in the context of this evaluation (PMID: 34514881, 24785942, 25168210). No submitters have reported clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. - |
not provided Pathogenic:1
Likely pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Aug 17, 2023 | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 27809427, 24785942, 33027950, 25168210, 34514881) - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at